A Study to Evaluate Rocatinlimab (AMG 451) in Healthy Chinese Participants

Clinical trial NCT06214481 · COMPLETED

Trial details

NCT number: NCT06214481
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2024-01-23
Primary completion: 2024-05-27
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.